209 related articles for article (PubMed ID: 30628650)
1. A thirteen‑gene set efficiently predicts the prognosis of glioblastoma.
Yang H; Jin L; Sun X
Mol Med Rep; 2019 Mar; 19(3):1613-1621. PubMed ID: 30628650
[TBL] [Abstract][Full Text] [Related]
2. Construction of Novel DNA Methylation-Based Prognostic Model to Predict Survival in Glioblastoma.
Zhao J; Wang L; Kong D; Hu G; Wei B
J Comput Biol; 2020 May; 27(5):718-728. PubMed ID: 31460783
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
4. A 63 signature genes prediction system is effective for glioblastoma prognosis.
Zhang Y; Xu J; Zhu X
Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370
[TBL] [Abstract][Full Text] [Related]
5. A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma.
Chai R; Zhang K; Wang K; Li G; Huang R; Zhao Z; Liu Y; Chen J
J Cancer Res Clin Oncol; 2018 Mar; 144(3):439-447. PubMed ID: 29299749
[TBL] [Abstract][Full Text] [Related]
6. Identification of Prognostic Biomarkers for Glioblastoma Based on Transcriptome and Proteome Association Analysis.
Wang J; Yan S; Chen X; Wang A; Han Z; Liu B; Shen H
Technol Cancer Res Treat; 2022; 21():15330338211035270. PubMed ID: 35538679
[TBL] [Abstract][Full Text] [Related]
7. Candidate Biomarkers and Molecular Mechanism Investigation for Glioblastoma Multiforme Utilizing WGCNA.
Yang Q; Wang R; Wei B; Peng C; Wang L; Hu G; Kong D; Du C
Biomed Res Int; 2018; 2018():4246703. PubMed ID: 30356407
[TBL] [Abstract][Full Text] [Related]
8. COL3A1 and SNAP91: novel glioblastoma markers with diagnostic and prognostic value.
Gao YF; Mao XY; Zhu T; Mao CX; Liu ZX; Wang ZB; Li L; Li X; Yin JY; Zhang W; Zhou HH; Liu ZQ
Oncotarget; 2016 Oct; 7(43):70494-70503. PubMed ID: 27655637
[TBL] [Abstract][Full Text] [Related]
9. lncRNA and mRNA signature for prognosis prediction of glioblastoma.
Liu G; Pan Y; Li Y; Xu H
Future Oncol; 2020 May; 16(13):837-848. PubMed ID: 32250161
[No Abstract] [Full Text] [Related]
10. Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme.
Li H; Wang D; Yi B; Cai H; Xi Z; Lou X; Li Z
Biomed Res Int; 2021; 2021():8357585. PubMed ID: 34395626
[TBL] [Abstract][Full Text] [Related]
11. A 4-gene panel predicting the survival of patients with glioblastoma.
Guo XX; Su J; He XF
J Cell Biochem; 2019 Sep; 120(9):16037-16043. PubMed ID: 31081973
[TBL] [Abstract][Full Text] [Related]
12. Ribosomal Proteins RPS11 and RPS20, Two Stress-Response Markers of Glioblastoma Stem Cells, Are Novel Predictors of Poor Prognosis in Glioblastoma Patients.
Yong WH; Shabihkhani M; Telesca D; Yang S; Tso JL; Menjivar JC; Wei B; Lucey GM; Mareninov S; Chen Z; Liau LM; Lai A; Nelson SF; Cloughesy TF; Tso CL
PLoS One; 2015; 10(10):e0141334. PubMed ID: 26506620
[TBL] [Abstract][Full Text] [Related]
13. A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer.
Fatai AA; Gamieldien J
BMC Cancer; 2018 Apr; 18(1):377. PubMed ID: 29614978
[TBL] [Abstract][Full Text] [Related]
14. A Potential Prognostic Gene Signature for Predicting Survival for Glioblastoma Patients.
Hou Z; Yang J; Wang H; Liu D; Zhang H
Biomed Res Int; 2019; 2019():9506461. PubMed ID: 31032367
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme.
Han J; Puri RK
J Neurooncol; 2018 Feb; 136(3):463-474. PubMed ID: 29168083
[TBL] [Abstract][Full Text] [Related]
16. Expression and clinical significance of CPS1 in glioblastoma multiforme.
Wu G; Yan Y; Zhou Y; Wang X; Wei J; Chen X; Lin W; Ou C; Zhou J; Xu Z
Curr Res Transl Med; 2019 Nov; 67(4):123-128. PubMed ID: 31492588
[TBL] [Abstract][Full Text] [Related]
17. Survival kinase genes present prognostic significance in glioblastoma.
Varghese RT; Liang Y; Guan T; Franck CT; Kelly DF; Sheng Z
Oncotarget; 2016 Apr; 7(15):20140-51. PubMed ID: 26956052
[TBL] [Abstract][Full Text] [Related]
18. Identification of
Lin H; Yang Y; Hou C; Zheng J; Lv G; Mao R; Xu P; Chen S; Zhou Y; Wang P; Zhou D
Genet Test Mol Biomarkers; 2021 May; 25(5):334-345. PubMed ID: 33970702
[No Abstract] [Full Text] [Related]
19. Identification of potential serum biomarkers of glioblastoma: serum osteopontin levels correlate with poor prognosis.
Sreekanthreddy P; Srinivasan H; Kumar DM; Nijaguna MB; Sridevi S; Vrinda M; Arivazhagan A; Balasubramaniam A; Hegde AS; Chandramouli BA; Santosh V; Rao MR; Kondaiah P; Somasundaram K
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1409-22. PubMed ID: 20530493
[TBL] [Abstract][Full Text] [Related]
20. Integrated Transcriptomic Analysis of Necrosis-related Gene in Diffuse Gliomas.
Wang J; Ma J
J Neurol Surg A Cent Eur Neurosurg; 2019 Jul; 80(4):240-249. PubMed ID: 30934097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
